AHRO Recent News AtheroNova Announces Preliminary

AHRO Recent News

AtheroNova Announces Preliminary Positive Phase 1 Clinical Data From Lead Drug AHRO-001, a Potential Treatment for Atherosclerosis GlobeNewswire - Thu Feb 27, 8:52AM CST
Liberty Software and VUCA Health Partner to Enhance Patient Safety and Provide Pharmacies with an Innovative Patient Engagement Tool PR Newswire - Fri Jan 17, 8:08AM CST
Global Microspheres Market Report 2013 - Global Trends & Forecasts to 2018 PR Newswire - Wed Jan 08, 1:13PM CST
10-K: ESTERLINE TECHNOLOGIES CORP Edgar Online - Fri Dec 20, 3:08PM CST
Farmers Files Lawsuit Seeking More Than $3 Million Against Radiological Corporations And Their Owners For Allegedly Billing For Services Never Rendered PR Newswire - Thu Dec 19, 10:32AM CST
AtheroNova Inc enrols 54 subjects in Russia under Phase 1 clinical trial of AHRO-001 for potential treatment of atherosclerosis M2 - Fri Dec 06, 9:55AM CST
AtheroNova Completes Enrollment in Phase 1 Clinical Trial of AHRO-001, a Potential Treatment for Atherosclerosis PR Newswire - Thu Dec 05, 6:00AM CST
Atherosclerosis Researcher Dr. Erik Stroes Joins AtheroNova's Clinical Advisory Board PR Newswire - Tue Oct 15, 6:00AM CDT
AtheroNova to Present at the 2013 Aegis Healthcare Conference in Las Vegas PR Newswire - Thu Sep 19, 6:00AM CDT
AtheroNova Inc. Presenting at 15th Annual Rodman & Renshaw Investment Conference Marketwire - Wed Sep 04, 12:08PM CDT